Phase II Pilot Study On The Effect Of Methylphenidate On Cognitive Function Of Patients In Remission Of Breast Cancer

Trial Profile

Phase II Pilot Study On The Effect Of Methylphenidate On Cognitive Function Of Patients In Remission Of Breast Cancer

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 02 Jun 2017

At a glance

  • Drugs Methylphenidate (Primary) ; Methylphenidate (Primary)
  • Indications Cognition disorders
  • Focus Therapeutic Use
  • Acronyms CogMet
  • Most Recent Events

    • 24 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top